Massive survey aims to map haemophilia in Asia-Pacific
NCT ID NCT07163260
First seen Oct 31, 2025 · Last updated Jun 07, 2026 · Updated 38 times
Summary
This study collects information from doctors and patient groups across Asia and the Pacific to better understand how haemophilia affects people in the region. No treatments or medications are given; instead, researchers will analyze data on how many people have the condition, how often new cases occur, and what care is currently available. The goal is to improve future care and support for people with haemophilia.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HAEMOPHILIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Novo Nordisk Investigational Site
Bangalore, Karnataka, 560 066, India
-
Novo Nordisk Investigational Site
Kuala Lumpur, 50470, Malaysia
-
Novo Nordisk Investigational Site
Seoul, South Korea
-
Novo Nordisk Investigational Site
Bangkok, 10500, Thailand
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.